Arca
Skip to content
Tools
Tools

70S ribosome

Protein nucleic-acid complex in Pseudomonas aeruginosa that 1 drug acts on.

  • Drugs that act on it: 1
  • Approved: 1
  • In phases 1 to 3: 0
  • Sponsors: 1
  • Genes: 56

Who is on it, and how far along

Every drug ChEMBL records acting on RPLA, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 1

Approved1

  • Tobramycin

Phase 30

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        DrugFurthest stageSponsorModalityActionOpen trials
        TobramycinBoxed warningApprovedReseluteSmall moleculeInhibitor70S ribosome inhibitor16

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 8 in all, from ClinicalTrials.gov.
        Local Antibiotic Delivery From an Intramedullary Nail After Surgical Treatment of Tibial Fractures at High Risk of InfectionTobramycinNot applicableNot yet recruitingReselute, Inc.Nov 10, 2026
        Tobramycin Nebulization to Prevent Multidrug-Resistant Ventilator-Associated PneumoniaTobramycinPhase 4Not yet recruitingSecond Affiliated Hospital, Zhejiang University, School of MedicineOct 2, 2026
        Microbiome-guided Prophylaxis to Reduce Ventilator-Associated Pneumonia in Intensive Care Units: A Pilot Randomized Controlled TrialTobramycinPhase 2Not yet recruitingUniversity of CalgaryMar 11, 2026
        Local Antibiotic Concentrations With Tissue Expanders in Breast ReconstructionTobramycinNot applicableNot yet recruitingUniversity of California, DavisJan 14, 2026
        Fluorometholone StudyTobramycinPhase 2Not yet recruitingVishal JhanjiDec 30, 2025
        Pivmecillinam as Oral Step-Down Treatment for Escherichia Coli Febrile Urinary Tract Infection Versus Standard of CareTobramycinPhase 4RecruitingUppsala UniversityNov 19, 2025
        Antibiotic Impregnated Beads in OsteomyelitisTobramycinPhase 4Not yet recruitingUniversity of ArizonaJul 18, 2025
        Long-term Impact of Inhaled Tobramycin for Pseudomonas Aeruginosa Eradication in Bronchiectasis (ERASE II)Tobramycin—RecruitingShanghai Pulmonary Hospital, Shanghai, ChinaJan 6, 2025

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2364022, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.